Use of the minimal clinically important difference (MCID) for evaluating treatment outcomes With TMJMD patients: A preliminary study

Megan Ingram, Yun Hee Choi, Rob Haggard, Angela Liegey Dougall, Robert J. Gatchel, Peter Buschang, Chung Yi Chiu

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Temporomandibular joint and muscle disorder (TMJMD) is one of the most prevalent types of musculoskeletal disorders. The major goal of the study was to more objectively quantify clinically meaningful relief for TMJMD treatment outcomes by using the new metric of minimal clinically important difference (MCID). Pre- to post-treatment changes on a number of self-report measures were evaluated in a cohort of 101 acute TMJMD patients. An anchor-based MCID approach was employed, with an objective chewing performance measure serving as the clinical outcome of interest. Using a Receiver Operating Curve analysis, it was found that the Physical Component Scale (PCS) of the SF-36 was the most robust self-report measure to use as the MCID in a TMJMD patient population.

Original languageEnglish
Pages (from-to)148-166
Number of pages19
JournalJournal of Applied Biobehavioral Research
Volume16
Issue number3-4
DOIs
StatePublished - Dec 2011

Fingerprint Dive into the research topics of 'Use of the minimal clinically important difference (MCID) for evaluating treatment outcomes With TMJMD patients: A preliminary study'. Together they form a unique fingerprint.

  • Cite this